Bacterial Cellulose based Microfluidic Point-of-Care Device for Antibiotic Susceptibility Testing
Implementing Organization
Indian Institute of Technology (IIT)
Principal Investigator
Dr. Mudrika Khandelwal
Indian Institute of Technology (IIT)
CO-Principal Investigator
Dr. Suhanya Duraiswamy
Indian Institute of Technology (IIT)
About
Antimicrobial resistance (AMR) is a global public health challenge due to the overuse of broad-spectrum antibiotics. Current gold standards for Antibiotic Susceptibility Testing (AST) are culture-based and take 8 hours or more, leading to inappropriate prescriptions. To address this issue, quick and efficient tests are needed to identify antibiotic resistance profiles. Paper-based lateral flow devices, such as pregnancy test kits, have gained attention due to their faster response, ease of use, and low cost. Plant-based cellulose is typically used, but it is not free from impurities and has limited surface area and porosity. Bacterial nanocellulose paper offers significant improvement due to its higher surface area and tunable nature. Bacterial Cellulose (BC) has a nanofibrous porous structure with high porosity and exceptional water holding capability.
The aim is to fabricate a lateral flow-based microfluidic device using BC, which can hold bacterial growth solution, antibiotic, and a halo-chromic dye. This device can detect antibiotic susceptibility by allowing resistant bacteria to grow and preventing growth at the minimum inhibitory concentration (MIC) if susceptible. The device's advantages over current plant-based platforms include excellent water retention capabilities, lower values of MIC, and ease of post-processing/assembling. Visual interpretation of susceptibility and MIC results is also possible. Bacterial cellulose devices offer faster detection using lower volumes of fluid and low-cost packaging. They can be easily produced by table-top culture and can be tuned during production to modulate pore size, porosity, and microfibres. Preliminary work by the team supports these advantages.
Source
Source
Anusandhan National Research Foundation/Science and Engineering Research Board (SERB), DST 2023-24
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Medical Sciences
Start Year
2024
End Year
2027
Sanction Amount
₹ 52.65 L
Status
Ongoing
Contact
mudrika@iith.ac.in
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed :00
Grant :00
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.